newsfilter
← Latest News
GlobeNewswire·

Kuehn Law Encourages Investors of Rhythm Pharmaceuticals, Inc. to Contact Law Firm

  • Kuehn Law, PLLC is investigating potential fiduciary duty breaches by Rhythm Pharmaceuticals, Inc. officers & directors.
  • The investigation focuses on allegations of self-dealing.
  • Shareholders may be entitled to damages & corporate governance reforms.
  • Long-term RYTM stockholders can contact Justin Kuehn, Esq. at justin@kuehn.law or (833) 672-0814 for a free consultation.
  • Kuehn Law covers all case costs & charges no fees to investor clients.
  • Shareholders are urged to contact the firm immediately due to potential time limits on enforcing rights.
  • Participation aims to enhance financial market integrity & fairness.
  • This is an attorney advertisement where prior results do not guarantee similar outcomes.